Daiken Biomedical Co (TPE:7780) Accounts Payable: NT$150 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:7780 Daiken Biomedical Co Ltd TPE:7780
24 GF Score
Price NT$17.30
! 6 Warning Signs
View Full Analysis

What is Daiken Biomedical Co Accounts Payable?

Daiken Biomedical Co TPE:7780 -3.35% 24 Accounts Payable is NT$150 Mil as of Dec. 2025. GuruFocus rates TPE:7780 with a GF Score™ of 24/100. The stock has 6 warning signs investors should review.

Daiken Biomedical Co's Accounts Payable for the quarter that ended in Dec. 2025 was NT$150 Mil.

Daiken Biomedical Co's quarterly Accounts Payable increased from Jun. 2025 (NT$120 Mil) to Sep. 2025 (NT$138 Mil) and increased from Sep. 2025 (NT$138 Mil) to Dec. 2025 (NT$150 Mil).

Daiken Biomedical Co's annual Accounts Payable increased from Dec. 2023 (NT$46 Mil) to Dec. 2024 (NT$72 Mil) and increased from Dec. 2024 (NT$72 Mil) to Dec. 2025 (NT$150 Mil).

Daiken Biomedical Co Accounts Payable Related Terms

Daiken Biomedical Co Accounts Payable Historical Data

* Premium members only.

The historical data trend for Daiken Biomedical Co's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Daiken Biomedical Co Accounts Payable Chart

Daiken Biomedical Co Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Accounts Payable
30.65 46.25 71.61 149.70

Daiken Biomedical Co Quarterly Data
Dec22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 71.61 88.93 120.43 137.99 149.70
TPE:7780
24GF Score
Daiken Biomedical Co Ltd TPE:7780
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Daiken Biomedical Co Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of NT$150 Mil mean?
Daiken Biomedical Co (TPE:7780) has a Accounts Payable of NT$150 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Daiken Biomedical Co and its competitors.
Is Daiken Biomedical Co's Accounts Payable too high?
Daiken Biomedical Co's current Accounts Payable is NT$150 Mil. Overall, Daiken Biomedical Co has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Daiken Biomedical Co's Accounts Payable compare to KHC and GIS?
Daiken Biomedical Co's Accounts Payable of NT$150 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Consumer Packaged Goods company?
A good Accounts Payable depends on the Consumer Packaged Goods industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Daiken Biomedical Co and its competitors. Daiken Biomedical Co's current Accounts Payable is NT$150 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daiken Biomedical Co stock overvalued right now?
Daiken Biomedical Co (TPE:7780) has a current Accounts Payable of NT$150 Mil. The current Accounts Payable is NT$150 Mil. Daiken Biomedical Co's overall GF Score™ is 24/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Daiken Biomedical Co (TPE:7780), the current Accounts Payable is NT$150 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Daiken Biomedical Co Business Description

Address Roosevelt Road, 12th Floor, No. 37, Section 3, Daan District, Taipei, TWN
Daiken Biomedical Co Ltd is engaged in Research, development, and sales of health food. Its products include fish oil capsules, collagen powder, collagen drinks, natto capsules, and mint leaf capsules. The companies reportable operating segment consists solely of the e-commerce division.
24GF Score

Get the complete analysis for TPE:7780

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$17.30
Price